Log in to save to my catalogue

Vasopressin and interactive calcium, cyclic AMP and purinergic signaling in Polycystic Kidney Diseas...

Vasopressin and interactive calcium, cyclic AMP and purinergic signaling in Polycystic Kidney Diseas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4539141

Vasopressin and interactive calcium, cyclic AMP and purinergic signaling in Polycystic Kidney Disease

About this item

Full title

Vasopressin and interactive calcium, cyclic AMP and purinergic signaling in Polycystic Kidney Disease

Journal title

Nature reviews. Nephrology, 2015-04, Vol.11 (8), p.451-464

Language

English

Formats

More information

Scope and Contents

Contents

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common monogenic kidney disease and the fourth leading cause of end-stage renal disease, responsible for 5–10% of cases. The disease is characterized by relentless development and growth of cysts causing progressive kidney enlargement associated with hypertension, pain, reduced qualit...

Alternative Titles

Full title

Vasopressin and interactive calcium, cyclic AMP and purinergic signaling in Polycystic Kidney Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4539141

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4539141

Other Identifiers

ISSN

1759-5061

E-ISSN

1759-507X

DOI

10.1038/nrneph.2015.39

How to access this item